Danaher DHR
NYSE DHR
$230.27 -1.89 (-0.81%)
As of: Nov 13, 2026 · 12:06 PM EST

Danaher (DHR) Gains from Sales and Divestitures (2011 - 2020)

Updated

Analysis

Danaher (DHR) Gains from Sales and Divestitures (2011 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn
3 Danaher 161.92 Bn 141.57 Bn 3.84 Bn
4 Intuitive Surgical 155.43 Bn 135.72 Bn 2.08 Bn
5 Medtronic 131.93 Bn 97.45 Bn 6.34 Bn
6 Stryker 119.74 Bn 105.93 Bn 4.25 Bn
7 Boston Scientific 64.30 Bn 59.73 Bn 3.43 Bn
8 Edwards Lifesciences 61.65 Bn 44.86 Bn 1.35 Bn
9 Agilent Technologies 48.79 Bn 41.68 Bn 1.04 Bn
10 GE HealthCare Technologies 37.34 Bn 25.57 Bn 2.22 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 400,000.00
Jul 3, 2020 455.00 Mn
Jul 1, 2011 201.70 Mn
API Access

Danaher Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DHR&period=max&api_key=YOUR_API_KEY